Table 3.

Genotypic drug resistance test results of 39 study participants on ART with viral load >1000 copies/mL

Study ID	Current ART	Previous ART	Viral load (copies/mL)	Mutations in RT
33	EFV/3TC/AZT	-	190,343	K103N,M184V
34	NVP/3TC/D4T	-	50,626	G190A,M184V,D67N,K219Q
65	NVP/3TC/D4T	-	118,402	V108I,Y181C,M184V,T210W
71	NVP/3TC/D4T	-	141,470	Y181C,M184V
87	EFV/3TC/D4T		30,661	K103N,V108I,M184V,T215F
88	EFV/3TC/AZT		42,764	K103N,P225H,M184V
92	NVP/3TC/D4T		34,335	Y181C,M184V
107	NVP/3TC/D4T	-	66,838	Y181C,M184V
150	NVP/3TC/D4T	-	1,309	K103N,V108I,M184V
158	EFV/3TC/AZT	NVP/D4T	220,347	K103N,V108I,P225H,M184V,M41L,D67N,K70R,V75M,T215Y,K219Q
160	NVP/3TC/D4T	EFV	32,840	Y181C,M184V,T69N
212	NVP/3TC/D4T	-	10,627	G190A,M184V
216	EFV/3TC/AZT	-	15,161	M41L
240	NVP/3TC/D4T	-	229,960	K103N,M184V
247	NVP/3TC/D4T	-	2,611	Y181C,G190A,M184V
302	NVP/3TC/D4T	EFV/AZT	3,564	K103N,Y181CM184V
326	EFV/3TC/AZT	NVP/D4T	148,750	K103N,G190A,M184V,D67N,K70R,K219Q
348	NVP/3TC/D4T	-	18,596	Y181C,M184V,K65R*
353	NVP/3TC/D4T	-	1,614	Y181C,M184V
354	NVP/3TC/D4T		4,326	K103N,V108I,M184V,T215F
364	NVP/3TC/D4T	-	17,232	K103N,M184V
377	NVP/3TC/D4T	-	13,088	G190A,M184V
380	EFV/3TC/AZT	-	2,814	K103N,G190A,M184V
407	NVP/3TC/D4T	-	25,634	G190A,M184V
427	NVP/3TC/D4T	-	98,367	K103N,M184V,T215Y
459	NVP/3TC/D4T	-	13,404	G190S,M184V
463	NVP/3TC/D4T	-	54,432	Y181C,G190A,M184V
467	NVP/3TC/D4T	-	30,253	M184V,D67N,K70R,K219E
472	NVP/3TC/D4T	ABV	11,806	G190A,M184V,D67N,K70R,K219Q
477	NVP/3TC/D4T	-	39,783	V108I,Y181C,M184V,D67N,K70R,K219Q
487	NVP/3TC/D4T	EFV/AZT/TDF	17,980	K103N,Y188L,M184V,M41L,L210W,T215Y

*Previous use of tenofovir, abacavir, didanosine not elicited

KEY: NVP = nevirapine, EFV = efavirenz, 3TC = lamivudine, D4T = stavudine, AZT = zidovudine, TDF = tenofovir, ABC = abacavir